INM
NASDAQ · Pharmaceuticals
Inmed Pharmaceuticals Inc
$1.46
+0.03 (+2.10%)
Open$1.44
Previous Close$1.43
Day High$1.49
Day Low$1.42
52W High$2.50
52W Low$0.58
Volume—
Avg Volume185.0K
Market Cap4.87M
P/E Ratio—
EPS$-2.88
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+2,204.8% upside
Current
$1.46
$1.46
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.90M | 10.21M | 790.8K |
| Net Income | -27,904,670 | -15,170,161 | 172.0K |
| Profit Margin | -165.1% | -156.9% | 21.8% |
| EBITDA | -26,440,165 | -15,172,550 | 218.3K |
| Free Cash Flow | — | — | 109.5K |
| Rev Growth | +65.6% | +65.6% | +11.4% |
| Debt/Equity | — | — | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |